Nexalin Technology Secures Legislative Support for Non-Invasive Neurostimulation Research at VA
Nexalin Technology, Inc. (NASDAQ: NXL) announced that its advocated report language was included in the U.S. House of Representatives' Fiscal Year 2027 Appropriations bill to expand research on non-invasive deep brain neurostimulation for traumatic brain injury among veterans.
Topics: neurostimulation research_funding traumatic_brain_injury veterans_affairs